Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 4
2006 1
2007 5
2008 6
2009 3
2010 1
2011 9
2012 4
2013 7
2014 9
2015 12
2016 10
2017 12
2018 10
2019 15
2020 23
2021 27
2022 36
2023 28
2024 22
2025 21
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study.
Perez-Gracia JL, Mellado B, Hansen AR, Alonso-Gordoa T, Gomez-Roca C, Løvendahl Eefsen R, Negrier S, Suárez C, Lee JL, Hussain A, Pedrazzoli P, Moreno V, Rodriguez-Vida A, Sosman JA, Waddell T, Bedke J, Park SH, Sznol M, Spychaj L, Andersson E, Julien-Laferriere A, Cheng WY, Watson C, Silva AP, Heichinger C, Staedler N, Sleiman N, Dejardin D, Boetsch C, Evers S, Vardar T, Ardeshir-Tandon C, Dorado Pérez J, Charo J, Keshelava N, Kraxner A, Teichgräber V, Powles T. Perez-Gracia JL, et al. Among authors: pedrazzoli p. J Immunother Cancer. 2026 Apr 9;14(4):e012466. doi: 10.1136/jitc-2025-012466. J Immunother Cancer. 2026. PMID: 41956546 Free article. Clinical Trial.
Interlesional genomic heterogeneity in small bowel adenocarcinoma: evidence from matched primary and peritoneal metastatic lesions.
Vanoli A, Parente P, De Lisi G, Travaglino E, Antoci F, Quaquarini E, Grillo F, Colella T, Antoniacomi C, Guerini C, Alberizzi P, Bortolotto C, Lenti MV, Pedrazzoli P, Fassan M, Paulli M, Di Sabatino A, Corallo S. Vanoli A, et al. Among authors: pedrazzoli p. Clin Res Hepatol Gastroenterol. 2026 Mar 25;50(5):102815. doi: 10.1016/j.clinre.2026.102815. Online ahead of print. Clin Res Hepatol Gastroenterol. 2026. PMID: 41895657
Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study.
Pantano F, Malgeri A, De Giorgi U, Maruzzo M, Fornarini G, Zucali P, Fratino L, Milella M, Pedrazzoli P, Procopio G, Stellato M, Naglieri E, Soto Parra H, Napoli MD, Mollica V, Tudini M, Pipitone S, Santoni M, Ricotta R, Banna GL, Catalano F, Cavo A, Vignani F, Masini C, Casadei C, Galli L, Nolè F, Sorarù M, Prati V, Panni S, Roviello G, Prati G, Morelli F, Messina C, Atzori F, Rescigno P, Santini D, Buti S, Rebuzzi SE. Pantano F, et al. Among authors: pedrazzoli p. Front Oncol. 2026 Feb 18;16:1754327. doi: 10.3389/fonc.2026.1754327. eCollection 2026. Front Oncol. 2026. PMID: 41788982 Free PMC article.
Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysis.
Dauccia C, Bruzzone M, Arecco L, Blondeaux E, Sirico M, Gerosa R, Franzoi MA, Brandão M, Perrone L, Pedrazzoli P, Desmedt C, Di Cosimo S, Vernieri C, Collet L, Lambertini M, de Azambuja E, Agostinetto E. Dauccia C, et al. Among authors: pedrazzoli p. Breast. 2026 Apr;86:104710. doi: 10.1016/j.breast.2026.104710. Epub 2026 Jan 27. Breast. 2026. PMID: 41650544 Free PMC article. Review.
Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database.
Sini C, Russo A, Cortinovis D, Muscarella LA, Tiseo M, Bria E, Grisanti S, Piovano P, Veccia A, Antonuzzo L, Citarella F, Pilotto S, Reale ML, Pignataro D, Roca E, Calvetti L, Pizzutilo P, Minuti G, Pelizzari G, Alì G, Bettini A, Pavan A, Signorelli D, Ricciardi S, Meoni G, Sergi C, Genova C, Scotti V, Vavalà T, Gori S, Pasello G, Pedrazzoli P, Chiari R, D'Aveni A, Buosi R, Toschi L, Parra HS, Buffoni L, Stanzione B, Ortega C, Zannori C, Giannarelli D, Malapelle U, Novello S, Passiglia F, Baldini E. Sini C, et al. Among authors: pedrazzoli p. Eur J Cancer. 2026 Feb 5;234:116191. doi: 10.1016/j.ejca.2025.116191. Epub 2025 Dec 24. Eur J Cancer. 2026. PMID: 41475048 Free article.
Adjuvant abemaciclib in early-stage breast cancer: hypothesis-generating safety observations from a real-world cohort study.
Sottotetti F, Figini S, Gambini G, Rizzo G, Chessa G, Quaquarini E, Palumbo R, Perrone L, Tagliaferri B, Ferrari A, Klersy C, Pedrazzoli P, Locati LD, Lasagna A. Sottotetti F, et al. Among authors: pedrazzoli p. Drugs Context. 2025 Dec 11;14:2025-7-5. doi: 10.7573/dic.2025-7-5. eCollection 2025. Drugs Context. 2025. PMID: 41424664 Free PMC article.
251 results